SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.36+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob zagorin who wrote (27734)1/30/1999 9:55:00 PM
From: Arthur Radley  Read Replies (2) of 32384
 
Bob,
I agree with you but would like to add...anyone investing in LGND shouldn't be doing it for Panretin and Ontak. Targretin is the drug that will make LGND and we should get information on the progress being made with Targretin in the not to distance future.
As for Panretin and Ontak, what other biotech will have TWO new drugs approved in such a short time frame and we all know, it will be the springboard for LGND into a profitable operation and not based on milestone payments from alliance partners. All just MO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext